ÂÜÀòÂÒÂ×

Nathaniel Swanson has a comprehensive work experience spanning multiple companies and roles. Nathaniel is currently working at Affini-T Therapeutics as a Senior Manager in Process Sciences, a position they have held since March 2023. Prior to this, they served as a Team Leader in Process Sciences at the same company from September 2021 to March 2023.

Before joining Affini-T Therapeutics, Nathaniel worked at PACT Pharma from 2019 to 2021. Nathaniel started as an Associate Scientist in Process Development in March 2020 and then progressed to become a Senior Research Associate in the same department from July 2019 to March 2020.

Prior to their time at PACT Pharma, Nathaniel gained experience at Genentech from 2017 to 2019. Nathaniel started as an Associate Engineer in the Process Development Rotation Program (PDRP) in August 2017 and later transitioned to the role of Engineer I from April to August 2019.

Nathaniel also has research experience from their tenure at the Massachusetts Institute of Technology (MIT). Nathaniel worked as a Research Associate from June 2015 to October 2016, leading a team in developing a scalable process for production of isotopically-enriched serum albumin using Pichia pastoris as a biosynthetic host. Additionally, they designed experiments and optimized albumin production using statistical software.

Earlier in their career, Nathaniel gained valuable industry experience through internships at Pfizer, Genzyme, New England Biolabs, and Ocean Genome Legacy, Inc. These roles provided him with exposure to various aspects of bioprocess development, validation engineering, enzymatic research, and virus production.

In summary, Nathaniel Swanson has a diverse work history in the biotechnology and pharmaceutical industry, showcasing their expertise in process sciences, research, and engineering.

Nathaniel Swanson pursued their higher education from 2012 to 2017 at the University of Massachusetts Lowell where they completed a Bachelor of Science degree in Chemical Engineering.